Literature DB >> 12494415

Plasma exchange: why we do what we do.

Mark E Brecher1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12494415     DOI： 10.1002/jca.10041

Source DB:  PubMed          Journal:  J Clin Apher        ISSN： 0733-2459            Impact factor:   2.821


× No keyword cloud information.
  13 in total

Review 1.  Current topics in therapeutic plasmapheresis.

Authors:  Takeshi Nakanishi; Naoki Suzuki; Takahiro Kuragano; Yasuyuki Nagasawa; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2013-07-26       Impact factor: 2.801

Review 2.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 3.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

4.  Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Min-Suk Yoon; Andrew Chan; Ralf Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

5.  Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study.

Authors:  Shaoying Tan; Tsz Kin Ng; Quangang Xu; Mo Yang; Yuan Zhuang; Jie Zhao; Huanfen Zhou; Da Teng; Shihui Wei
Journal:  Ther Adv Neurol Disord       Date:  2020-08-21       Impact factor: 6.570

6.  Plasma exchange in severe attacks of neuromyelitis optica.

Authors:  Mickael Bonnan; Philippe Cabre
Journal:  Mult Scler Int       Date:  2012-02-12

Review 7.  Is Antimicrobial Treatment Effective During Therapeutic Plasma Exchange? Investigating the Role of Possible Interactions.

Authors:  Łukasz J Krzych; Marcelina Czok; Zbigniew Putowski
Journal:  Pharmaceutics       Date:  2020-04-25       Impact factor: 6.321

8.  Therapeutic Efficacy of Plasma Exchange in Neuromyelitis Optica.

Authors:  Rajesh Kumar; Birinder Singh Paul; Gagandeep Singh; Amarjit Kaur
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

9.  Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.

Authors:  Su-Hyun Kim; Woojun Kim; So-Young Huh; Kyue Yim Lee; In Ja Jung; Ho Jin Kim
Journal:  J Clin Neurol       Date:  2013-01-03       Impact factor: 3.077

10.  Estimation of intrathecal IgG synthesis: simulation of the risk of underestimation.

Authors:  Mickael Bonnan; Mariana Gianoli-Guillerme; Henri Courtade; Stéphanie Demasles; Elsa Krim; Raluca Marasescu; Hervé Dréau; Stéphane Debeugny; Bruno Barroso
Journal:  Ann Clin Transl Neurol       Date:  2018-03-24       Impact factor: 4.511
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.